Opthea Expects To Receive The Remaining $35M Committed Funds Under Development Funding Agreement With Carlyle And Abingworth
Portfolio Pulse from Benzinga Newsdesk
Opthea is set to receive the remaining $35 million from Carlyle and Abingworth as part of a development funding agreement. This financing is non-dilutive, meaning no new equity will be issued to the investors.
December 27, 2023 | 11:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Opthea is poised to receive the last tranche of $35M from its development funding agreement with Carlyle and Abingworth, which will not dilute current shareholders as it involves no new equity issuance.
The completion of the funding agreement is positive news for Opthea as it provides financial resources without affecting shareholder value through dilution. This could be seen as a vote of confidence by the investors and may positively influence the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100